furosemide has been researched along with torsemide in 171 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (11.11) | 18.7374 |
| 1990's | 42 (24.56) | 18.2507 |
| 2000's | 52 (30.41) | 29.6817 |
| 2010's | 37 (21.64) | 24.3611 |
| 2020's | 21 (12.28) | 2.80 |
| Authors | Studies |
|---|---|
| Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alonso-Galicia, M; Bailey, T; Brochu, RM; de Jesus, RK; Ding, FX; Ehrhart, J; Felix, JP; Garcia, ML; Gu, X; Ha, S; Hampton, C; Hernandez, M; Jiang, J; Kaczorowski, GJ; Owens, K; Pai, LY; Parmee, ER; Pasternak, A; Pio, B; Priest, BT; Roy, S; Shahripour, A; Sullivan, K; Swensen, AM; Tang, H; Teumelsan, N; Thomas-Fowlkes, B; Walsh, SP; Yang, L; Zhou, X; Zhu, Y | 1 |
| Hayashi, K; Kido, H; Uchida, T; Watanabe, M | 1 |
| Hayashi, K; Kido, H; Uchida, T; Watanabe, M; Yamanaga, K | 1 |
| Beck, FX; Dörge, A; Sone, M; Thurau, K | 1 |
| Carlesi, RM; Cavigioli, G; Foresi, A; Marazzini, L; Mastropasqua, B; Pelucchi, A | 1 |
| Brater, DC | 1 |
| Krämer, B; Müller, GA; Risler, T | 1 |
| Kido, H; Nishikawa, M; Ohtaki, Y; Uchida, T; Watanabe, M; Yamanaga, K | 1 |
| Hayashi, K; Matsumura, Y; Suzuki, Y; Uchida, T | 1 |
| Azzena, G; Buzzelli, G; De Feo, ML; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Meacci, E | 1 |
| Boeynaems, JM; Deger, F; Derenne, F; Douchamps, J; Herchuelz, A; Juvent, M; Staroukine, M; Van Ganse, E; Verniory, A | 1 |
| Bockaert, J; Pin, JP; Recasens, M | 1 |
| Dupont, AG; Gerlo, E; Laekeman, G; Piepsz, A; Van der Niepen, P | 1 |
| Brunner, G; Häcker, W; von Bergmann, K; von Möllendorff, E | 1 |
| Broekhuysen, J; Deger, F; Douchamps, J; Ducarne, H; Herchuelz, A | 2 |
| Grosswendt, J; Haecker, W; Klütsch, K | 1 |
| Haecker, W; Mion, C; Mourad, G | 1 |
| Glocke, M; Häcker, W; Kult, J | 1 |
| Delarge, J | 1 |
| Lesne, M | 1 |
| Dodion, L; Lameire, N | 1 |
| Anderson, SA; Brater, DC; Leinfelder, J | 1 |
| Ambroes, Y; Dodion, L; Lameire, N | 1 |
| Delarge, J; Luyckx, AS; Scheen, AJ; Vancrombreucq, JC | 1 |
| de Suray, JM; Delarge, J; Denef, J; Georges, A; Gerin, M; Ghys, A; Willems, J | 1 |
| Delarge, J; Denef, J; Georges, A; Ghys, A | 1 |
| Denef, J; Ghys, A; Kramp, RA; Lenoir, RH | 1 |
| Dodion, L; Kesteloot, H; Stroobandt, R | 1 |
| Reyes, AJ | 1 |
| Adams, KF; Blose, JS; Patterson, JH | 1 |
| Black, PK; Brater, DC; Kramer, WG; Serpas, T; Smith, WB; Vargo, DL | 1 |
| Casali, E; Castellani, ET; Mattioli, AV; Mattioli, G | 1 |
| Kido, H; Ohtaki, Y; Uchida, T; Watanabe, M; Yamanaga, K | 1 |
| Andreucci, VE; Minutolo, R; Russo, D | 1 |
| Elia, GF; Fiaccadori, F; Pasetti, GC; Pedretti, G; Pizzaferri, P | 1 |
| Knauf, H; Mutschler, E | 1 |
| Beck, FX; Dörge, A; Ohno, A; Thurau, K | 1 |
| Brater, DC; Gehr, TW; Kramer, WG; Matzke, GR; Rudy, DW; Sica, DA | 1 |
| Bremner, S; Hariman, RJ; Jones, JP; Kostis, JB; Louie, EK; Nocero, MA; Rogers, WJ | 1 |
| Bertheau-Reitha, U; Falkner, C; Gerbes, AL; Jüngst, D; Paumgartner, G | 1 |
| Elia, G; Fiaccadori, F; Pasetti, G; Pedretti, G; Pizzaferri, P | 1 |
| Schlatter, E | 1 |
| Giebisch, G; Klein-Robbenhaar, G; Klein-Robbenhaar, J; Ratheiser, K; Unwin, R | 1 |
| Leary, WP; Reyes, AJ | 1 |
| Silke, B | 1 |
| Kindler, J | 1 |
| Carloni, V; Foschi, M; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Romanelli, RG | 1 |
| Chen, BP | 1 |
| Hayashi, K; Okano, K; Sogame, Y; Tsuda, Y; Uchida, T | 1 |
| Onyefuru, LC; Rice, P; Upshall, DG | 1 |
| Bernareggi, A; Buzzelli, G; Carloni, V; Chibbaro, G; Cotrozzi, G; Foschi, M; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Melani, L; Quartini, M; Simoni, A; Tommasi, AC | 1 |
| Bodini, P; Dizioli, P; Marelli, A; Quinzani, M; Reggiani, A; Tonghini, L | 1 |
| Allison, ME; Quinn, KJ; Shilliday, IR | 1 |
| Fisher, ML; Gottlieb, SS; Khatta, M; Kramer, WG; Roffman, D; Wentworth, D | 1 |
| Bähr, V; Ball, DL; Goodfriend, TL; Oelkers, W | 1 |
| Löffler-Walz, C; Quast, U | 1 |
| Berman, BN; Bryant, J; Heaton, AH; Trotter, JP | 1 |
| Andreini, I; Casini, A; Di Loreto, M; Liguori, A; Napoli, C | 1 |
| Noe, LL; Pezzella, SM; Trotter, JP; Vreeland, MG | 1 |
| Díez, J; Fortuño, A; Fortuño, MA; Muñiz, P; Ravassa, S; Rodriguez, JA; Zalba, G | 1 |
| Dreckmann-Behrendt, B; Goertz, A; Spannheimer, A | 1 |
| Kelso, E; McDermott, B; Silke, B; Spiers, P | 1 |
| Brater, DC; Forthofer, MM; Murray, MD; Stroupe, KT | 1 |
| Allison, ME; Shilliday, IR | 1 |
| Abecasis, R; Cobas, S; Guevara, M; Miguez, C; Terg, R | 1 |
| Díez, J; Fortuño, A; Fortuño, MA; Muñiz, P; Zalba, G | 2 |
| Kido, H; Ohtaki, Y | 1 |
| Adams, LD; Bennett, SJ; Brater, DC; Deer, MM; Dexter, PR; Ferguson, JA; Lane, KA; Murray, MD; Perkins, SM; Smith, FE; Tierney, WM | 1 |
| Cohn, JN | 1 |
| Cosín, J; Díez, J | 1 |
| Falkenstein, P; Follath, F; Gutzwiller, F; Müller, K; Reitberger, U; Spannheimer, A | 1 |
| Akutagawa, O; Fukuda, M; Hayashi, T; Honda, K; Okamoto, M; Sasaki, T; Yamato, M | 1 |
| Agarwal, R; Saha, C; Vasavada, N | 1 |
| Agarwal, R; Vasavada, N | 1 |
| Fukushima, U; Ishikawa, Y; Kaneko, T; Kuwajima, E; Matsuoka, M; Uechi, M; Yamashita, K | 1 |
| Gamba, G; Hess, B; Jaquet, F; Müller, K | 1 |
| Bard, RL; Bleske, BE; Nicklas, JM | 1 |
| Díez, J; González, A; Larman, M; López, B; Querejeta, R; Sánchez, E | 1 |
| Dohke, T; Fujii, M; Horie, M; Ishikawa, C; Ohno, K; Sakai, H; Takayama, T; Tsutamoto, T; Wada, A; Yamamoto, T | 1 |
| Martin, M; Morgera, S; Spies, C; Staegemann, M; Vargas Hein, O; von Heymann, C; Wagner, D | 1 |
| Han, SW; Kim, HJ; Oh, MS | 1 |
| Hatori, T; Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Eshaghian, S; Fonarow, GC; Horwich, TB | 1 |
| Chuen, MJ; MacFadyen, RJ | 1 |
| de Berrazueta, JR; de Mier, I; García-Unzueta, MT; González, JP; Poveda, JJ | 1 |
| Bagshaw, SM; Bellomo, R; Delaney, A; Ghali, WA; Haase, M | 1 |
| Brockmöller, J; Meineke, I; Nürnberg, P; Schirmer, M; Sehrt, D; Toliat, MR; Tzvetkov, M; Vormfelde, SV | 1 |
| Beaumont, J; Díez, J; González, A; Larman, M; López, B; Querejeta, R | 2 |
| Higuchi, S; Hori, Y; Hoshi, F; Ikadai, H; Takusagawa, F; Uechi, M | 1 |
| Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Schenk, H; Schlesinger, S; Spies, C; von Dossow, V; von Heymann, C | 1 |
| Cantarovich, F; Hoste, E; Mehta, RL; Murray, P; Shaw, A | 1 |
| Baughman, KL; Desai, AS; Fang, JC; Givertz, MM; Lewis, EF; Mielniczuk, LM; Nohria, A; Stevenson, LW; Tsang, SW | 1 |
| Ishido, H; Senzaki, H | 1 |
| Anguita, M; Castillo, JC; León, C; Toledano, F | 1 |
| Brown, J; Collins, MA; Neafsey, EJ; Sripathirathan, K | 1 |
| Nicklas, J; Pitt, B | 1 |
| Aizawa, Y; Harima, M; Kodama, M; Tachikawa, H; Tanaka, H; Thanikachalam, PV; Watanabe, K; Yamaguchi, K | 1 |
| Anguita, M; Castro-Beiras, A; Cobo, E; Coca, A; Conthe, P; de Teresa, E; Díez, J; Fernández, E | 1 |
| Acuña, C | 1 |
| He, XY; Li, Q; Qi, ZY; Xiao, QW; Xu, J; Zeng, J | 1 |
| Oyama, MA; Peddle, GD; Reynolds, CA; Singletary, GE | 1 |
| Machen, MC; Oyama, MA; Peddle, GD; Reynolds, CA; Singletary, GE; Trafny, DJ | 1 |
| Bikdeli, B; Coca, SG; Dharmarajan, K; Khan, U; Kim, N; Krumholz, HM; Li, SX; Partovian, C; Strait, KM; Testani, JM | 1 |
| Cicoira, M; Dini, FL; Genta, FT; Ghio, S; Klersy, C; Rossi, A; Scelsi, L; Simioniuc, A; Tavazzi, L; Temporelli, PL | 1 |
| Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Dittrich, HC; Fiuzat, M; Givertz, MM; Hillege, HL; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Valente, MA; Van Veldhuisen, DJ; Voors, AA | 1 |
| Afrin, R; Arumugam, S; Giridharan, VV; Harima, M; Karuppagounder, V; Miyashita, S; Pitchaimani, V; Sreedhar, R; Suzuki, K; Thandavarayan, RA; Watanabe, K | 1 |
| Brockmöller, J; Dalila, N; Haubrock, M; Schirmer, M; Tzvetkov, MV; Vormfelde, SV | 1 |
| Anstrom, KJ; Buggey, J; Eisenstein, EL; Mentz, RJ; O'Connor, CM; Pitt, B; Velazquez, EJ | 1 |
| Drożdż, J; Filipiak, KJ; Mamcarz, A; Nessler, J; Niemczyk, M; Tykarski, A; Wożakowska-Kapłon, B | 1 |
| Anstrom, KJ; Buggey, J; DeVore, AD; Eisenstein, EL; Ersbøll, MK; Fiuzat, M; Mentz, RJ; OʼConnor, CM; Schulte, PJ; Velazquez, EJ | 1 |
| Antonijoan, RM; Ballester, MR; Delgadillo, J; Gich, I; Puntes, M; Roig, E; Santos, B | 1 |
| Chiswell, K; Fiuzat, M; Givertz, MM; McKendry, C; Mentz, RJ; Metra, M; O'Connor, CM; Teerlink, JR; Velazquez, EJ; Voors, AA | 1 |
| Anstrom, KJ; Armstrong, PW; DeVore, AD; Ezekowitz, JA; Hasselblad, V; Hernandez, AF; Mentz, RJ; Metra, M; O'Connor, CM; Schulte, PJ; Tang, WH; Velazquez, EJ; Voors, AA | 1 |
| Antony, S; Arumugam, S; Giridharan, VV; Harima, M; Karuppagounder, V; Nakamura, M; Sone, H; Sreedhar, R; Suzuki, H; Suzuki, K; Thandavarayan, RA; Watanabe, K | 1 |
| Bakuła, E; Balsam, P; Cacko, A; Filipiak, KJ; Fojt, A; Grabowski, M; Główczyńska, R; Huczek, Z; Kowalik, R; Markulis, M; Opolski, G; Ozierański, K; Peller, M; Sieradzki, B; Tymińska, A | 1 |
| Adin, D; Johnson, PR; Kim, CH; Nguyenba, T; Rosen, S | 1 |
| Blanc, J; Chetboul, V; Desquilbet, L; Lucats, L; Menard, J; Petit, A; Pouchelon, JL; Rougier, S; Woehrle, F | 1 |
| Greene, SJ; Mentz, RJ | 1 |
| Yao, Y; Zhang, J; Zhang, R; Zhang, Y | 1 |
| Doshi, R; Mithawala, P; Patel, H; Shah, P | 1 |
| Balsam, P; Crespo-Leiro, MG; Drożdż, J; Filipiak, KJ; Grabowski, M; Kapłon-Cieślicka, A; Kowalik, R; Maggioni, AP; Marchel, M; Opolski, G; Ozierański, K; Peller, M; Tymińska, A; Wancerz, A | 1 |
| Anstrom, KJ; Eisenstein, EL; Gabriel, D; Greene, SJ; Harding, T; Harrington, A; Jones, I; Mentz, RJ; Prather, K; Velazquez, EJ | 1 |
| Agewall, S; Atar, D; Clark, AL; Cleland, JGF; Frankenstein, L; Fröhlich, H; Goode, K; Grundtvig, M; Hole, T; Katus, HA; Kazmi, S; Schellberg, D; Seiz, M; Täger, T | 1 |
| Chen, M; Hanumanthu, BK; Kokkinidis, DG; Miles, JA; Patel, K; Siegel, RM | 1 |
| Klek, S; Pietka, M; Watrobska-Swietlikowska, D | 1 |
| Ahmed, D; Assi, AAR; Habra, M; Rahhal, A; Saad, MO; Tawengi, K | 1 |
| Al-Habbaa, A; Eid, PS; Elkady, AH; Elsayed, GG; Elshafay, A; Hirayama, K; Huy, NT; Kien, ND; Minh, LHN; Mohammed, AT; Morra, ME; Nghia, TLB; Sherif, NA; Thanh, LV; Turk, T; Y, MN | 1 |
| Ames, MK; Hess, A; Poglitsch, M; Potter, BM | 1 |
| Bakuła, E; Balsam, P; Bednarski, J; Cacko, A; Filipiak, KJ; Fojt, A; Gawałko, M; Grabowski, M; Główczyńska, R; Kowalik, R; Marchel, M; Markulis, M; Niedziela, Ł; Niewiński, G; Opolski, G; Ozierański, K; Peller, M; Sieradzki, B; Sieradzki, M; Tymińska, A | 1 |
| Baduashvili, A | 1 |
| Chan, JSK; Harky, A | 1 |
| Besche, B; Blondel, T; Garelli-Paar, C; Guillot, E; Oyama, MA | 1 |
| Abouibrahim, MA; Do, VBD; Duy, LM; Eid, PS; Elfaituri, MK; Elrahman, MMA; Fahmy, MM; Hirayama, K; Huy, NT; Ibrahim, DA; Kandil, H; Minh, LHN; Shah, J; Shehata, MAA; Shinkar, A; Tam, DNH; Vuong, NL; Zayan, AH | 1 |
| Alvarado, MP; Barbarino, A; Chetboul, V; Delle Cave, J; Depré, B; Ghazal, S; Lefort, S; Marchal, CR; Passavin, P; Poissonnier, C; Saponaro, V; Tissier, R; Trehiou-Sechi, E; Vannucci, E; Verwaerde, P | 1 |
| Guo, Z; Li, L; Li, Y; Zhang, S | 1 |
| Anstrom, KJ; Desvigne-Nickens, P; Eisenstein, EL; Greene, SJ; Harding, T; Ketema, F; Kim, DY; Mentz, RJ; Morgan, S; Pitt, B; Sachdev, V; Sapp, S; Velazquez, EJ | 1 |
| DeWald, TA; Greene, SJ; Mentz, RJ; Peters, AE | 1 |
| Bell, R; Bruce, S; Cooper, LB; deFilippi, C; Mentz, R; O'Connor, C; Psotka, M; Seliger, SL | 1 |
| Anstrom, KJ; Eisenstein, EL; Greene, SJ; Harding, T; Harrington, A; Kim, DY; Mentz, RJ; Sachdev, V; Sapp, S; Velazquez, EJ | 1 |
| Fukuda, K; Goda, A; Imaeda, S; Kohno, T; Kohsaka, S; Nagatomo, Y; Nakano, S; Niimi, N; Saji, M; Shiraishi, Y; Takei, M; Yoshikawa, T | 1 |
| Broeckx, BJG; de Salazar Alcala, AG; Devreese, M; Hellemans, A; Paepe, D; Roche-Catholy, M; Schneider, M; Smets, P; Woehrlé, F | 1 |
| Menon, V; Verbrugge, FH | 1 |
| Gramer, M; Kirchhoff, L; Löscher, W; Schmidt, R; Welzel, B | 1 |
| Anstrom, KJ; Desvigne-Nickens, P; Eisenstein, EL; Greene, SJ; Harrington, AH; Ketema, F; Kim, DY; Mentz, RJ; Morgan, S; Pitt, B; Sachdev, V; Sapp, S; Testani, JM; Velazquez, EJ | 1 |
| DeWald, TA; Mentz, RJ; Velazquez, EJ | 1 |
| Wolowich, WR | 1 |
| Alexy, T; Ambrosy, AP; Anstrom, KJ; Clare, RM; Desvigne-Nickens, P; DeWald, TA; Eisenstein, EL; Greene, SJ; Ketema, F; Kim, DY; Mentz, RJ; Pitt, B; Psotka, MA; Rommel, JJ; Stevens, GR; Velazquez, EJ | 1 |
| Hill, PB; Hosseini, F; Hosseininejad, M; Mahmoudi Filabadi, Z | 1 |
| Kulkarni, NS | 1 |
23 review(s) available for furosemide and torsemide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical pharmacology of loop diuretics.
Topics: Bumetanide; Diuretics; Furosemide; Humans; Sulfonamides; Torsemide | 1991 |
The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.
Topics: Acute Kidney Injury; Diuretics; Furosemide; Humans; Kidney Failure, Chronic; Sulfonamides; Torsemide | 1991 |
Torsemide: a pyridine-sulfonylurea loop diuretic.
Topics: Clinical Trials as Topic; Diuretics; Drug Interactions; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Renal Insufficiency; Sulfonamides; Torsemide | 1995 |
Comparative analysis of torasemide and furosemide in liver cirrhosis.
Topics: Clinical Trials as Topic; Diuretics; Edema; Furosemide; Humans; Liver Cirrhosis; Sulfonamides; Torsemide | 1994 |
Renal and extrarenal sites of action of diuretics.
Topics: Animals; Diuretics; Furosemide; Kidney Tubules; Loop of Henle; Nephrons; Potassium; Sodium; Sulfonamides; Torsemide | 1993 |
Clinicopharmacological reappraisal of the potency of diuretics.
Topics: Clopamide; Diuretics; Furosemide; Humans; Hydrochlorothiazide; Muzolimine; Natriuresis; Pyridines; Sulfonamides; Torsemide; Xipamide | 1993 |
Central hemodynamic effects of diuretic therapy in chronic heart failure.
Topics: Bumetanide; Cardiac Output; Diuresis; Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans; Muzolimine; Plasma Volume; Sulfonamides; Torsemide | 1993 |
Torasemide in advanced renal failure.
Topics: Administration, Oral; Biological Availability; Calcium; Diuretics; Furosemide; Half-Life; Humans; Injections, Intravenous; Kidney Failure, Chronic; Renal Dialysis; Sulfonamides; Torsemide | 1993 |
Loop diuretics: comparison of torsemide, furosemide, and bumetanide.
Topics: Bumetanide; Diuretics; Furosemide; Humans; Sulfonamides; Torsemide | 1996 |
[Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
Topics: Animals; Clinical Trials as Topic; Diuretics; Edema, Cardiac; Furosemide; Heart Failure; Humans; Hypokalemia; Mineralocorticoid Receptor Antagonists; Sulfonamides; Torsemide | 2001 |
Food: an unrecognized source of loop diuretic resistance.
Topics: Administration, Oral; Area Under Curve; Bumetanide; Clinical Trials as Topic; Diuresis; Diuretics; Food; Furosemide; Humans; Intestinal Absorption; Sulfonamides; Torsemide | 2004 |
Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis.
Topics: Acid-Base Equilibrium; Acute Kidney Injury; Creatinine; Critical Illness; Data Interpretation, Statistical; Female; Furosemide; Humans; Length of Stay; Male; Middle Aged; Odds Ratio; Potassium; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Time Factors; Torsemide; Treatment Outcome | 2007 |
Torasemide for the treatment of heart failure.
Topics: Animals; Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Quality of Life; Sulfonamides; Torsemide | 2008 |
[Hypertension, hypertensive heart disease and heart failure. Role of loop diuretics].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Echocardiography, Doppler; Furosemide; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Meta-Analysis as Topic; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Sulfonamides; Torsemide | 2008 |
[Update: prolonged-release torasemide].
Topics: Animals; Chronic Disease; Delayed-Action Preparations; Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide | 2010 |
A reappraisal of loop diuretic choice in heart failure patients.
Topics: Choice Behavior; Fibrosis; Furosemide; Heart; Heart Failure; Humans; Myocardium; Practice Patterns, Physicians'; Renin-Angiotensin System; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Up-Regulation; Ventricular Dysfunction, Left | 2015 |
Torsemide versus furosemide in heart failure patients: A meta-analysis of randomized controlled trials.
Topics: Furosemide; Heart Failure; Humans; Patient Readmission; Randomized Controlled Trials as Topic; Time Factors; Torsemide; Treatment Outcome | 2018 |
Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
Topics: Furosemide; Heart Failure; Humans; Observational Studies as Topic; Patient Readmission; Randomized Controlled Trials as Topic; Recovery of Function; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Torsemide; Treatment Outcome | 2019 |
Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
Topics: Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide; Treatment Outcome | 2020 |
Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide | 2021 |
Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Prospective Studies; Randomized Controlled Trials as Topic; Torsemide; Treatment Outcome | 2021 |
An evaluation of torsemide in patients with heart failure and renal disease.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Multicenter Studies as Topic; Sodium Potassium Chloride Symporter Inhibitors; Torsemide | 2022 |
62 trial(s) available for furosemide and torsemide
| Article | Year |
|---|---|
Effect of inhaled furosemide and torasemide on bronchial response to ultrasonically nebulized distilled water in asthmatic subjects.
Topics: Administration, Inhalation; Adolescent; Adult; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Diuretics; Double-Blind Method; Female; Forced Expiratory Volume; Furosemide; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Sulfonamides; Torsemide; Water | 1992 |
The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.
Topics: Acute Kidney Injury; Diuretics; Furosemide; Humans; Kidney Failure, Chronic; Sulfonamides; Torsemide | 1991 |
Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study.
Topics: Ascites; Diuretics; Double-Blind Method; Furosemide; Humans; Liver Cirrhosis; Sulfonamides; Torsemide | 1991 |
Renal pharmacodynamic effects of torasemide and furosemide in normal man.
Topics: Adult; Catecholamines; Creatinine; Diuretics; Dopamine; Furosemide; Glomerular Filtration Rate; Humans; Kidney; Male; Prostaglandins E; Reference Values; Renal Circulation; Renin; Sulfonamides; Torsemide; Urine | 1988 |
Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver.
Topics: Administration, Oral; Body Weight; Clinical Trials as Topic; Diuresis; Diuretics; Double-Blind Method; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Random Allocation; Spectrophotometry, Ultraviolet; Sulfonamides; Torsemide | 1988 |
Comparative pharmacodynamics of torasemide and furosemide in patients with oedema.
Topics: Aged; Aged, 80 and over; Blood Pressure; Blood Urea Nitrogen; Body Weight; Clinical Trials as Topic; Creatinine; Diuretics; Double-Blind Method; Edema; Female; Furosemide; Humans; Male; Middle Aged; Random Allocation; Sodium; Sulfonamides; Torsemide; Urea; Uric Acid | 1988 |
Single dose comparison of torasemide and furosemide in patients with advanced renal failure.
Topics: Adult; Aged; Blood Pressure; Chlorides; Clinical Trials as Topic; Creatinine; Diuretics; Double-Blind Method; Female; Furosemide; Heart Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Potassium; Random Allocation; Sodium; Sulfonamides; Torsemide | 1988 |
Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.
Topics: Adult; Aged; Clinical Trials as Topic; Creatinine; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Electrolytes; Female; Furosemide; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Random Allocation; Sulfonamides; Torsemide | 1988 |
Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Creatinine; Diuretics; Double-Blind Method; Electrolytes; Female; Furosemide; Humans; Kidney Failure, Chronic; Male; Middle Aged; Random Allocation; Sodium; Sulfonamides; Torsemide; Uric Acid | 1988 |
Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
Topics: Administration, Oral; Adult; Biological Availability; Diuretics; Electrolytes; Furosemide; Half-Life; Humans; Injections, Intravenous; Male; Reference Values; Sulfonamides; Torsemide | 1988 |
Acute and chronic effects of torasemide in healthy volunteers.
Topics: Chromatography, High Pressure Liquid; Diuretics; Female; Furosemide; Humans; Male; Potassium; Sodium; Sulfonamides; Time Factors; Torsemide; Water-Electrolyte Balance | 1988 |
Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
Topics: Aged; Aged, 80 and over; Body Weight; Clinical Trials as Topic; Creatinine; Diuretics; Double-Blind Method; Edema; Female; Furosemide; Humans; Hypertension; Kinetics; Male; Middle Aged; Random Allocation; Sulfonamides; Torsemide; Urea; Uric Acid; Urine | 1986 |
Clinical pharmacology of torasemide, a new loop diuretic.
Topics: Adult; Diuretics; Dose-Response Relationship, Drug; Furosemide; Humans; Kinetics; Male; Nephrons; Probenecid; Random Allocation; Sulfonamides; Torsemide | 1987 |
A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
Topics: Adult; Creatinine; Diuretics; Electrolytes; Furosemide; Humans; Infusions, Intravenous; Male; Middle Aged; Random Allocation; Sulfonamides; Torsemide; Water-Electrolyte Balance | 1986 |
Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
Topics: Aged; Calcium; Chronic Disease; Creatinine; Diuretics; Double-Blind Method; Drug Evaluation; Electrolytes; Female; Furosemide; Heart Failure; Humans; Male; Osmolar Concentration; Phosphates; Random Allocation; Sulfonamides; Torsemide; Urine | 1986 |
Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Electrolytes; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Sulfonamides; Torsemide | 1982 |
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biological Availability; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Sulfonamides; Torsemide | 1995 |
Symptomatic achievements with diuretics in congestive heart failure.
Topics: Diuretics; Exercise Test; Female; Furosemide; Heart Failure; Humans; Jugular Veins; Male; Middle Aged; Sulfonamides; Torsemide; Venous Pressure | 1994 |
Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
Topics: Ascites; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Spironolactone; Sulfonamides; Torsemide; Xipamide | 1994 |
The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency.
Topics: Administration, Oral; Bumetanide; Diuretics; Double-Blind Method; Furosemide; Humans; Injections, Intravenous; Kidney Failure, Chronic; Sulfonamides; Torsemide | 1994 |
Dose-response study of intravenous torsemide in congestive heart failure.
Topics: Adult; Aged; Chlorides; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Potassium; Sodium; Sulfonamides; Torsemide; Urine | 1994 |
Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial.
Topics: Adult; Aged; Ascites; Diuretics; Double-Blind Method; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Sulfonamides; Torsemide | 1993 |
Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study.
Topics: Ascites; Diuretics; Double-Blind Method; Drug Therapy, Combination; Furosemide; Humans; Liver Cirrhosis; Spironolactone; Sulfonamides; Torsemide | 1993 |
Torasemide in the treatment of patients with cirrhosis and ascites.
Topics: Adult; Aged; Ascites; Body Weight; Canrenoic Acid; Combined Modality Therapy; Diet, Sodium-Restricted; Diuretics; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Potassium; Sulfonamides; Torsemide | 1993 |
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
Topics: Adult; Aged; Ascites; Diuretics; Drug Resistance; Female; Furosemide; Gas Chromatography-Mass Spectrometry; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney; Liver Cirrhosis; Male; Middle Aged; Potassium; Prostaglandins; Sodium; Sulfonamides; Torsemide | 1996 |
[Comparison between torasemide and furosemide in the treatment of ascites in cirrhotic patients].
Topics: Ascites; Diuretics; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Sulfonamides; Torsemide | 1997 |
Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Diuresis; Diuretics; Double-Blind Method; Female; Furosemide; Humans; Male; Middle Aged; Placebos; Prospective Studies; Sulfonamides; Torsemide | 1997 |
A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Managed Care Programs; Quality of Life; Random Allocation; Sulfonamides; Surveys and Questionnaires; Torsemide | 1999 |
Healthcare costs of patients with heart failure treated with torasemide or furosemide.
Topics: Adult; Aged; Diuretics; Drug Costs; Female; Furosemide; Health Care Costs; Heart Failure; Humans; Male; Middle Aged; Sulfonamides; Torsemide | 2000 |
Intraplatelet calcium levels in patients with acute renal failure before and after the administration of loop diuretics.
Topics: Acute Kidney Injury; Adult; Arginine Vasopressin; Blood Platelets; Calcium; Chelating Agents; Diuretics; Double-Blind Method; Egtazic Acid; Female; Furosemide; Humans; Male; Sulfonamides; Torsemide | 2001 |
Long-term efficacy of torsemide compared with frusemide in cirrhotic patients with ascites.
Topics: Adult; Aged; Analysis of Variance; Ascites; Chi-Square Distribution; Diuretics; Drug Administration Schedule; Female; Follow-Up Studies; Furosemide; Humans; Liver Cirrhosis; Liver Function Tests; Long-Term Care; Male; Middle Aged; Probability; Severity of Illness Index; Sulfonamides; Torsemide; Treatment Outcome | 2001 |
Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.
Topics: Aged; Biological Availability; Diuretics; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Quality of Life; Sulfonamides; Torsemide; Treatment Outcome | 2001 |
Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Echocardiography, Doppler; Female; Follow-Up Studies; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurotransmitter Agents; Regression Analysis; Sulfonamides; Torsemide; Ventricular Dysfunction, Left | 2003 |
A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Diuretics; Double-Blind Method; Female; Furosemide; Humans; Kidney Failure, Chronic; Male; Middle Aged; Natriuresis; Sodium; Sulfonamides; Torsemide | 2003 |
Role of excess volume in the pathophysiology of hypertension in chronic kidney disease.
Topics: Aged; Blood Pressure; Body Fluids; Cross-Over Studies; Diuretics; Female; Furosemide; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Middle Aged; Sulfonamides; Torsemide; Water-Electrolyte Imbalance | 2003 |
Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Chronic Disease; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Primary Health Care; Prospective Studies; Quality of Life; Sulfonamides; Torsemide; Treatment Outcome | 2003 |
Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure.
Topics: Collagen Type I; Diuretics; Echocardiography; Endomyocardial Fibrosis; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Pilot Projects; Sulfonamides; Torsemide; Treatment Outcome | 2004 |
Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure.
Topics: Aldosterone; Diuretics; Female; Furosemide; Heart; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardium; Sulfonamides; Torsemide | 2004 |
Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients.
Topics: Acute Kidney Injury; Adult; Aged; Chi-Square Distribution; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Furosemide; Humans; Kidney Function Tests; Male; Middle Aged; Probability; Prospective Studies; Reference Values; Renal Dialysis; Risk Assessment; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Sulfonamides; Torsemide; Treatment Outcome | 2005 |
Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.
Topics: Aged; Autonomic Nervous System Diseases; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Observer Variation; Stroke Volume; Sulfonamides; Tomography, Emission-Computed, Single-Photon; Torsemide; Ventricular Remodeling | 2006 |
Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugs.
Topics: Adult; Bumetanide; Cross-Over Studies; Diuretics; Epithelial Sodium Channels; Furosemide; Genotype; Haplotypes; Humans; Kidney; Male; Middle Aged; Phenotype; Polymorphism, Genetic; Potassium; Receptors, Drug; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Sulfonamides; Symporters; Thiazides; Torsemide | 2007 |
Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.
Topics: Adult; Aged; Antihypertensive Agents; Blotting, Western; Endocardium; Extracellular Matrix; Female; Fibrosis; Furosemide; Heart; Heart Failure; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Middle Aged; Myocardium; Peptide Fragments; Pilot Projects; Procollagen; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Torsemide | 2007 |
Secondary pulmonary hypertension: haemodynamic effects of torasemide versus furosemide.
Topics: Administration, Oral; Aged; Angiotensin II; Antihypertensive Agents; Cardiac Output; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin-1; Female; Furosemide; Hemodynamics; Humans; Hypertension, Pulmonary; Injections, Intravenous; Lung; Male; Middle Aged; Pilot Projects; Prospective Studies; Stroke Volume; Sulfonamides; Torsemide; Treatment Outcome | 2008 |
Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure.
Topics: Aged; Collagen; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Prospective Studies; Protein-Lysine 6-Oxidase; Sulfonamides; Torsemide; Ultrasonography; Up-Regulation; Ventricular Dysfunction, Left | 2009 |
TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
Topics: Chronic Disease; Collagen Type I; Delayed-Action Preparations; Diuretics; Female; Fibrosis; Furosemide; Heart Failure; Humans; Male; Peptide Fragments; Procollagen; Prospective Studies; Research Design; Sulfonamides; Torsemide | 2009 |
[Treatment of nephritic edema by torasemide in children].
Topics: Child; Child, Preschool; Diuretics; Edema; Female; Furosemide; Humans; Male; Nephrotic Syndrome; Sulfonamides; Torsemide | 2011 |
Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
Topics: Aged; Biomarkers; Chronic Disease; Delayed-Action Preparations; Diuretics; Endpoint Determination; Female; Fibrosis; Furosemide; Heart Failure; Humans; Hypertension; Male; Myocardium; Peptide Fragments; Procollagen; Prospective Studies; Sulfonamides; Torsemide; Treatment Outcome | 2011 |
Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
Topics: Animals; Cross-Over Studies; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Mitral Valve Insufficiency; Sulfonamides; Torsemide | 2012 |
Diuretic response in acute heart failure: clinical characteristics and prognostic significance.
Topics: Acute Disease; Aged; Analysis of Variance; Atherosclerosis; Bumetanide; Diabetes Complications; Diuretics; Dose-Response Relationship, Drug; Drug Resistance; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hypotension; Male; Patient Readmission; Renal Insufficiency; Sulfonamides; Torsemide; Treatment Outcome; Weight Loss; Xanthines | 2014 |
Impact of mineralocorticoid receptor polymorphisms on urinary electrolyte excretion with and without diuretic drugs.
Topics: Adolescent; Adult; Bumetanide; Cross-Over Studies; Diuretics; Electrolytes; Furosemide; Genetic Association Studies; Humans; Hydrochlorothiazide; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Potassium; Receptors, Mineralocorticoid; Single-Blind Method; Sodium Chloride; Sulfonamides; Torsemide; Triamterene; Young Adult | 2015 |
Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
Topics: Aged; Aged, 80 and over; Chemistry, Pharmaceutical; Chronic Disease; Cross-Over Studies; Delayed-Action Preparations; Furosemide; Heart Failure; Humans; Middle Aged; Natriuresis; Sodium Potassium Chloride Symporter Inhibitors; Spain; Sulfonamides; Time Factors; Torsemide; Treatment Outcome; Urination | 2015 |
Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.
Topics: Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Europe; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Sulfonamides; Survival Rate; Time Factors; Torsemide; Treatment Outcome | 2015 |
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
Topics: Acute Disease; Aged; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Furosemide; Global Health; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome | 2016 |
The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
Topics: Biomarkers; Chronic Disease; Clinical Protocols; Echocardiography; Electrocardiography, Ambulatory; Furosemide; Heart Failure; Hemodynamics; Humans; Neurotransmitter Agents; Poland; Quality of Life; Recovery of Function; Research Design; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Surveys and Questionnaires; Time Factors; Torsemide; Treatment Outcome; Ventricular Remodeling; Walk Test | 2017 |
Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study.
Topics: Animals; Diuretics; Dogs; Female; Furosemide; Heart Failure; Heart Valve Diseases; Male; Mitral Valve; Prospective Studies; Sulfonamides; Torsemide; Treatment Outcome | 2017 |
Comparison between the effects of torsemide and furosemide on the renin-angiotensin-aldosterone system of normal dogs.
Topics: Animals; Cross-Over Studies; Diuretics; Dogs; Furosemide; Male; Renin-Angiotensin System; Torsemide | 2019 |
Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial.
Topics: Aged; Comparative Effectiveness Research; Exercise Tolerance; Female; Furosemide; Heart Failure; Humans; Male; Pilot Projects; Poland; Preliminary Data; Recovery of Function; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Torsemide; Treatment Outcome | 2019 |
Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Male; Mitral Valve; Sulfonamides; Torsemide | 2020 |
Comparative effectiveness of furosemide vs torasemide in symptomatic therapy in heart failure patients: A randomized controlled study protocol.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide | 2021 |
Ascertaining Death Events in a Pragmatic Clinical Trial: Insights From the TRANSFORM-HF Trial.
Topics: Furosemide; Heart Failure; Humans; Reproducibility of Results; Torsemide; United States | 2022 |
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Topics: Aged; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Patient Discharge; Sodium Potassium Chloride Symporter Inhibitors; Torsemide; Treatment Outcome | 2023 |
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Topics: Furosemide; Heart Failure; Humans; Quality of Life; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Torsemide | 2023 |
87 other study(ies) available for furosemide and torsemide
| Article | Year |
|---|---|
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold.
Topics: Animals; Diuresis; Dogs; Heart Failure; Humans; Hypertension; Macaca mulatta; Oxazines; Potassium Channels, Inwardly Rectifying; Rats, Sprague-Dawley; Transcriptional Regulator ERG | 2016 |
Diuretic action of the novel loop diuretic torasemide in the presence of angiotensin II or endothelin-1 in anaesthetized dogs.
Topics: Acute Kidney Injury; Anesthesia; Angiotensin II; Animals; Blood Pressure; Diuretics; Dogs; Endothelins; Female; Furosemide; Glomerular Filtration Rate; Insulin; Loop of Henle; Male; Potassium; Renal Circulation; Sodium; Sulfonamides; Torsemide; Urodynamics | 1992 |
Torasemide, but not frusemide, increases intracellular cAMP and cGMP content in the aorta of the renal hypertensive rat.
Topics: Animals; Aorta; Blood Pressure; Cyclic AMP; Cyclic GMP; Diuretics; Furosemide; Hypertension, Renovascular; Male; Rats; Rats, Inbred Strains; Sulfonamides; Torsemide | 1992 |
Effect of loop diuretics on organic osmolytes and cell electrolytes in the renal outer medulla.
Topics: Animals; Diuretics; Electrolytes; Furosemide; Kidney Medulla; Male; Osmolar Concentration; Rats; Rats, Wistar; Sulfonamides; Torsemide | 1992 |
Anti-aldosteronergic effect of torasemide.
Topics: Administration, Oral; Aldosterone; Animals; Diuretics; Furosemide; Male; Rats; Rats, Inbred Strains; Renin; Sulfonamides; Torsemide | 1991 |
Effects of torasemide on renal haemodynamics and function in anaesthetized dogs.
Topics: Anesthesia; Animals; Diuretics; Dogs; Female; Furosemide; Hemodynamics; Kidney; Male; Potassium; Renal Circulation; Sodium; Sulfonamides; Torsemide | 1991 |
Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Diet, Sodium-Restricted; Diuretics; Furosemide; Humans; Indomethacin; Male; Metabolic Clearance Rate; Sodium; Sodium, Dietary; Sulfonamides; Torsemide | 1989 |
Chloride transport blockers inhibit the chloride-dependent glutamate binding to rat brain membranes.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Biphenyl Compounds; Brain; Chlorides; Ethacrynic Acid; Furosemide; Glutamates; Glutamic Acid; In Vitro Techniques; Kinetics; Male; Membranes; Rats; Rats, Inbred Strains; Sulfonamides; Torsemide | 1987 |
Chemistry and pharmacological properties of the pyridine-3-sulfonylurea derivative torasemide.
Topics: Animals; Blood Proteins; Chemical Phenomena; Chemistry; Diuretics; Furosemide; Injections, Intravenous; Male; Phenylbutazone; Protein Binding; Rats; Rats, Inbred Strains; Sulfonamides; Torsemide | 1988 |
Pharmacological properties of the new potent diuretic torasemide in rats and dogs.
Topics: Animals; Antihypertensive Agents; Blood Proteins; Cats; Desoxycorticosterone; Diuresis; Diuretics; Dogs; Electrolytes; Furosemide; Hemodynamics; Hypertension; Male; Protein Binding; Rats; Rats, Inbred Strains; Species Specificity; Sulfonamides; Tissue Distribution; Torsemide | 1985 |
Renal effects of the high ceiling diuretic torasemide in rats and dogs.
Topics: Anesthesia; Animals; Diuretics; Dogs; Electrolytes; Furosemide; Glomerular Filtration Rate; Kidney; Male; p-Aminohippuric Acid; Rats; Rats, Inbred Strains; Species Specificity; Sulfonamides; Time Factors; Torsemide | 1985 |
Effects of the diuretic torasemide on p-aminohippuric acid transport in the rat.
Topics: Aminohippuric Acids; Animals; Biological Transport, Active; Diuretics; Furosemide; Glomerular Filtration Rate; Inulin; Kidney Tubules; Male; Microinjections; p-Aminohippuric Acid; Probenecid; Rats; Rats, Inbred Strains; Sulfonamides; Torsemide | 1985 |
Renal excretory profiles of loop diuretics: consequences for therapeutic application.
Topics: Diuresis; Diuretics; Furosemide; Humans; Loop of Henle; Sulfonamides; Torsemide | 1993 |
Diuretic and vasodilating actions of torasemide.
Topics: Aldosterone; Animals; Desoxycorticosterone; Diuretics; Furosemide; In Vitro Techniques; Male; Potassium; Rats; Rats, Wistar; Renin; Sulfonamides; Torsemide; Vasodilator Agents | 1994 |
Role of loop diuretics in chronic renal failure.
Topics: Administration, Oral; Diuretics; Furosemide; Humans; Injections, Intravenous; Kidney Failure, Chronic; Natriuresis; Nephrotic Syndrome; Potassium; Sulfonamides; Torsemide | 1994 |
Loop diuretics affect transcellular electrolyte transport in cells of the distal convoluted tubule.
Topics: Animals; Biological Transport; Diuretics; Furosemide; Kidney Tubules, Distal; Male; Rats; Rats, Wistar; Rubidium; Sodium; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Torsemide | 1994 |
Effect of various diuretics on membrane voltage of macula densa cells. Whole-cell patch-clamp experiments.
Topics: Animals; Barium; Cell Line; Cell Membrane; Chloride Channels; Diuretics; Electric Conductivity; Electrophysiology; Furosemide; Hydrochlorothiazide; Kidney; Membrane Potentials; Membrane Proteins; Muzolimine; Potassium; Potassium Channels; Sulfonamides; Torsemide | 1993 |
Urinary excretion profile of torasemide and its diuretic action in dogs.
Topics: Animals; Diuretics; Dogs; Female; Furosemide; Injections, Intravenous; Male; Nephrons; Protein Binding; Sulfonamides; Torsemide | 1996 |
Effects of furosemide, torasemide and controlled fluid intake on perfluoroisobutene induced lung oedema and mortality.
Topics: Animals; Body Weight; Diuretics; Drinking; Female; Fluorocarbons; Furosemide; Hematocrit; Lung; Myocardium; Organ Size; Pulmonary Edema; Rats; Rats, Wistar; Sulfonamides; Torsemide | 1996 |
The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure.
Topics: Aged; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Severity of Illness Index; Sulfonamides; Torsemide | 1998 |
Torsemide inhibits aldosterone secretion in vitro.
Topics: Aldosterone; Animals; Cattle; Diuretics; Dose-Response Relationship, Drug; Furosemide; Guinea Pigs; Rats; Sulfonamides; Torsemide; Zona Glomerulosa | 1998 |
Interaction of the diuretics torasemide and U-37883A with the K(ATP) channel in rat isolated aorta.
Topics: Adamantane; Adenosine Triphosphate; Animals; Aorta; Binding, Competitive; Diuretics; Dose-Response Relationship, Drug; Furosemide; In Vitro Techniques; Isometric Contraction; Male; Morpholines; Potassium Channels; Protein Binding; Rats; Rats, Sprague-Dawley; Rubidium; Rubidium Radioisotopes; Sulfonamides; Torsemide | 1998 |
Pharmacoeconomic comparison of loop diuretics in the treatment of congestive heart failure.
Topics: Aged; Cost Control; Diuretics; Drug Costs; Drug Utilization Review; Female; Furosemide; Health Care Costs; Heart Failure; Hospitalization; Humans; Male; Managed Care Programs; Middle Aged; Patient Compliance; Sulfonamides; Torsemide | 1996 |
Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure.
Topics: 6-Ketoprostaglandin F1 alpha; Diuretics; Endothelium, Vascular; Epithelium; Epoprostenol; Female; Furosemide; Heart Failure; Hemodynamics; Humans; In Vitro Techniques; Kidney; Male; Middle Aged; Sulfonamides; Thromboxane B2; Torsemide; Vasodilator Agents | 1999 |
Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Biphenyl Compounds; Calcium; Cells, Cultured; Endothelium, Vascular; Furosemide; Hypertension; Intracellular Membranes; Irbesartan; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Sulfonamides; Tetrazoles; Torsemide; Vasoconstriction | 1999 |
Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Cross-Sectional Studies; Diuretics; Economics, Pharmaceutical; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Retrospective Studies; Sulfonamides; Torsemide | 1998 |
Positive effect of bumetanide on contractile activity of ventricular cardiomyocytes.
Topics: Animals; Bumetanide; Calcium Channels, L-Type; Cardiotonic Agents; Diuretics; Furosemide; Heart Ventricles; Isoproterenol; Male; Myocardial Contraction; Rabbits; Sulfonamides; Torsemide | 2000 |
[Decreased mortality. Help for the failing heart].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome | 2000 |
Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Biphenyl Compounds; Carrier Proteins; Cell Division; Cells, Cultured; Chlorides; Diuretics; Furosemide; Irbesartan; Leucine; Loop of Henle; Muscle, Smooth, Vascular; Potassium; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium; Sodium-Potassium-Chloride Symporters; Sulfonamides; Tetrazoles; Thymidine; Torsemide | 2001 |
The loop diuretic torasemide interferes with endothelin-1 actions in the aorta of hypertensive rats.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Bosentan; Calcium; Chloride Channels; Diuretics; Endothelin-1; Endothelium, Vascular; Furosemide; In Vitro Techniques; Kinetics; Muscle, Smooth, Vascular; ortho-Aminobenzoates; Rats; Rats, Inbred SHR; Sulfonamides; Torsemide; Vasoconstriction | 2001 |
Optimal diuretic therapy for heart failure.
Topics: Biological Availability; Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide | 2001 |
Torasemide in chronic heart failure: results of the TORIC study.
Topics: Aged; Chronic Disease; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Potassium; Product Surveillance, Postmarketing; Stroke Volume; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome; Ventricular Function, Left | 2002 |
[Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Cost-Benefit Analysis; Diuretics; Female; Furosemide; Germany; Heart Failure; Humans; Long-Term Care; Male; Middle Aged; Patient Admission; Retrospective Studies; Sulfonamides; Switzerland; Torsemide | 2002 |
[A better diuretic for patients with heart failure. Better control of potassium loss].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia; Sulfonamides; Torsemide; Treatment Outcome | 2002 |
[Which loop diuretic for heart failure? For prognosis the choices are not all the same].
Topics: Chronic Disease; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Randomized Controlled Trials as Topic; Sulfonamides; Survival Rate; Torsemide | 2002 |
[Reducing hospital stay and costs in heart failure. The proper diuretic makes the difference].
Topics: Clinical Trials as Topic; Cost Savings; Diuretics; Furosemide; Heart Failure; Hospital Costs; Humans; Length of Stay; Sulfonamides; Torsemide | 2003 |
[Hear failure. Indications for diuretic therapy in general practice].
Topics: Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide; Water-Electrolyte Balance | 2003 |
[Favorable prognostic effect of heart failure therapy. Diuretic makes heart muscle more elastic].
Topics: Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Myocardial Contraction; Prognosis; Sulfonamides; Torsemide; Treatment Outcome | 2003 |
[Diuretics in heart failure. Fewer electrolyte disorders -- better prognosis].
Topics: Chronic Disease; Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia; Prognosis; Sulfonamides; Time Factors; Torsemide | 2003 |
The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats.
Topics: Animals; Cats; Diuresis; Diuretics; Dogs; Female; Furosemide; Male; Reference Values; Sulfonamides; Time Factors; Torsemide | 2003 |
[Heart failure therapy. Cheap can become expensive].
Topics: Clinical Trials as Topic; Cost Savings; Diuretics; Drug Costs; Furosemide; Germany; Heart Failure; Humans; Patient Readmission; Sulfonamides; Survival Analysis; Torsemide | 2003 |
Comparison of the urine acidification tests of torsemide vs furosemide in healthy volunteers.
Topics: Adult; Diuretics; Furosemide; Humans; Hydrogen-Ion Concentration; Male; Reference Values; Sulfonamides; Torsemide; Urinalysis; Urine | 2005 |
Relation of loop diuretic dose to mortality in advanced heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bumetanide; California; Creatinine; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Prognosis; Stroke Volume; Sulfonamides; Survival Analysis; Torsemide | 2006 |
Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bumetanide; California; Creatinine; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Prognosis; Stroke Volume; Sulfonamides; Survival Analysis; Torsemide; Ventricular Dysfunction, Left | 2006 |
Vasodilatory action of loop diuretics: a plethysmography study of endothelial function in forearm arteries and dorsal hand veins in hypertensive patients and controls.
Topics: Adult; Arteries; Diuretics; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Forearm; Furosemide; Hand; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Plethysmography; Regional Blood Flow; Sulfonamides; Torsemide; Vasodilator Agents; Veins | 2007 |
Effects of oral administration of furosemide and torsemide in healthy dogs.
Topics: Administration, Oral; Animals; Blood Proteins; Blood Urea Nitrogen; Body Weight; Creatinine; Diuretics; Dogs; Female; Furosemide; Hematocrit; Male; Placebos; Sulfonamides; Torsemide; Urine | 2007 |
Comparative effects of torasemide and furosemide in rats with heart failure.
Topics: Animals; Collagen Type III; Cytochrome P-450 CYP11B2; Diuretics; Furosemide; Heart Failure; Immunohistochemistry; Male; Myocardium; Rats; Rats, Inbred Lew; Sulfonamides; Survival Rate; Torsemide; Transforming Growth Factor beta1; Ventricular Function, Left | 2008 |
Pharmacologic approaches for volume excess in acute kidney injury (AKI).
Topics: Acute Kidney Injury; Ascites; Bumetanide; Diuretics; Fluid Therapy; Furosemide; Heart Failure; Hepatorenal Syndrome; Humans; Kidney; Kidney Failure, Chronic; Liver Cirrhosis; Natriuretic Agents; Nephrotic Syndrome; Renal Replacement Therapy; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Ultrafiltration; Water-Electrolyte Imbalance | 2008 |
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.
Topics: Ambulatory Care; Ambulatory Care Facilities; Antihypertensive Agents; Bumetanide; Comorbidity; Diuretics; Female; Furosemide; Health Status Indicators; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Sulfonamides; Torsemide; Treatment Outcome | 2008 |
Linking binge alcohol-induced neurodamage to brain edema and potential aquaporin-4 upregulation: evidence in rat organotypic brain slice cultures and in vivo.
Topics: Acetazolamide; Alcohol Drinking; Animals; Antioxidants; Aquaporin 4; Blotting, Western; Brain Edema; Chromans; Dentate Gyrus; Diuretics; Entorhinal Cortex; Furosemide; Nerve Degeneration; Organ Culture Techniques; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sulfonamides; Torsemide; Up-Regulation; Water | 2009 |
Loop diuretics in patients with heart failure: time to change to torsemide?
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2009 |
[Effects of various diuretics on cardiac function in rats with heart failure].
Topics: Animals; Cytochrome P-450 CYP11B2; Disease Models, Animal; Diuretics; Furosemide; Heart Failure; Hemodynamics; Male; Myocardium; Rats; Rats, Inbred Lew; Spironolactone; Sulfonamides; Torsemide; Ventricular Remodeling | 2009 |
Use of the loop diuretic torsemide in three dogs with advanced heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Euthanasia, Animal; Fatal Outcome; Female; Furosemide; Heart Failure; Male; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2011 |
Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?
Topics: Databases, Factual; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Survival Analysis; Torsemide; Treatment Outcome | 2013 |
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Propensity Score; Renal Insufficiency, Chronic; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Ventricular Dysfunction, Left; Young Adult | 2013 |
Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy.
Topics: Animals; Blood Glucose; Body Weight; Diabetic Nephropathies; Disease Models, Animal; Diuretics; Echocardiography; Furosemide; Heme Oxygenase-1; Kidney; Male; NADH, NADPH Oxidoreductases; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Streptozocin; Sulfonamides; Torsemide | 2014 |
[Loop diuretics: old and new ones--which one to choose in clinical practice? Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy and Working Group on Heart Failure].
Topics: Cardiology; Furosemide; Heart Failure; Humans; Poland; Societies, Medical; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2015 |
Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.
Topics: Academic Medical Centers; Aged; Comorbidity; Databases, Factual; Female; Furosemide; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; North Carolina; Retrospective Studies; Risk Factors; Sex Factors; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Tertiary Care Centers; Torsemide; Treatment Outcome; Ultrasonography | 2015 |
Comparative effects of torasemide and furosemide on gap junction proteins and cardiac fibrosis in a rat model of dilated cardiomyopathy.
Topics: Animals; Cadherins; Cardiac Myosins; Cardiomyopathy, Dilated; Connexin 43; Connexins; Disease Models, Animal; Furosemide; Gene Expression Regulation; Heart Failure; Humans; Rats; Sulfonamides; Swine; Torsemide | 2017 |
Long-term Stability of a Compounded Suspension of Torsemide (5 mg/mL) for Oral Administration.
Topics: Administration, Oral; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Compounding; Drug Stability; Drug Storage; Furosemide; Pharmaceutical Solutions; Pharmaceutical Vehicles; Refrigeration; Sulfonamides; Suspensions; Temperature; Torsemide | 2017 |
Potential advantages of torsemide in patients with heart failure: more than just a 'water pill'?
Topics: Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide; Water | 2018 |
Can Torsemide and Combination of Loop Diuretics Improve Mortality in Patients with Chronic Heart Failure After Discharge?
Topics: Aged; China; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Proportional Hazards Models; Sulfonamides; Torsemide | 2018 |
Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
Topics: Aged; Disease Progression; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Poland; Recovery of Function; Registries; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Torsemide; Treatment Outcome | 2019 |
Death: The Simple Clinical Trial Endpoint.
Topics: Clinical Trials as Topic; Data Collection; Diuretics; Endpoint Determination; Furosemide; Heart Failure; Humans; Mortality; Torsemide | 2019 |
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
Topics: Aged; Blood Pressure; Bumetanide; Cause of Death; Europe; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Survival Rate; Torsemide; Treatment Outcome; Ventricular Function, Left | 2019 |
Evaluation of Y-site compatibility of home total parenteral nutrition and intravenous loop diuretics.
Topics: Administration, Intravenous; Drug Incompatibility; Furosemide; Humans; Hydrogen-Ion Concentration; Parenteral Nutrition, Home Total; Particle Size; Renal Insufficiency, Chronic; Sodium Potassium Chloride Symporter Inhibitors; Torsemide | 2019 |
Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
Topics: Aged; Drug Substitution; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Patient Readmission; Qatar; Retrospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Torsemide; Treatment Outcome | 2019 |
Simpson's Paradox: Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure.
Topics: Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Torsemide | 2020 |
Simpson's Paradox in Meta-Analysis - Choice of Studies and Summary Statistics.
Topics: Data Interpretation, Statistical; Furosemide; Heart Failure; Humans; Torsemide | 2020 |
Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016-2019).
Topics: Animals; Cat Diseases; Cats; Diuretics; Female; Furosemide; Heart Failure; Male; Retrospective Studies; Torsemide; Treatment Outcome | 2020 |
Proteomic differences among patients with heart failure taking furosemide or torsemide.
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Proteomics; Torsemide | 2022 |
Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
Topics: Aged; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Sodium Potassium Chloride Symporter Inhibitors; Torsemide | 2022 |
Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats.
Topics: Aldosterone; Animals; Cats; Creatinine; Diuretics; Dogs; Electrolytes; Furosemide; Humans; Potassium; Sodium; Sulfonamides; Torsemide | 2022 |
Torsemide comparison with furosemide for management of heart failure (TRANSFORM-HF) trial.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Torsemide; Treatment Outcome | 2022 |
The loop diuretic torasemide but not azosemide potentiates the anti-seizure and disease-modifying effects of midazolam in a rat model of birth asphyxia.
Topics: Animals; Asphyxia; Bumetanide; Diuretics; Epilepsy; Furosemide; Rats; Sodium Potassium Chloride Symporter Inhibitors; Solute Carrier Family 12, Member 2; Torsemide | 2023 |
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure-Reply.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Patient Discharge; Sulfonamides; Torsemide | 2023 |
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Patient Discharge; Sulfonamides; Torsemide | 2023 |
Evaluation of the short-term echocardiographic effects of two loop diuretics, furosemide and torsemide, in a group of dogs.
Topics: Animals; Diuretics; Dogs; Echocardiography; Furosemide; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2023 |
No Benefit With Torsemide Over Furosemide for Posthospitalization Treatment of Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide | 2023 |